What's breaking now, across thousands of outlets.
There will also be art therapy sessions and stress management programmes at the centre.
We haven't written up this one. Straits Times has the full story — the link below goes straight to it.
Contineum Therapeutics and Johnson & Johnson’s oral M1 receptor inhibitor has missed its second mid-stage study in a year, this time in major depressive disorder.
[Vanguard] GOMBE -- The All Progressives Congress (APC), Gombe State chapter, has accused the Peoples Democratic Party (PDP) of politicising the diphtheria outbreak in the state, describing the…
Jorge Martin suffered another physical setback during the San Marino GP weekend, adding to the injuries that have plagued him since he joined Aprilia last year.
For nearly 50 years, Shimon Sakaguchi has been studying and working on regulatory T cells, figuring out how the immune system "governs itself." Now, the Nobel laureate's decade-old biotech RegCell is…
Vera Therapeutics said two-year data show its recently approved drug Trutakna stabilized kidney function in patients with a chronic autoimmune disease, setting the drug up for another FDA submission.
THIS summer’s outbreak of West Nile virus in Andalucia has claimed its third victim after a patient infected with the disease died in Sevilla.
